MY149604A - C.perfringens alpha toxoid vaccine - Google Patents
C.perfringens alpha toxoid vaccineInfo
- Publication number
- MY149604A MY149604A MYPI20061722A MYPI20061722A MY149604A MY 149604 A MY149604 A MY 149604A MY PI20061722 A MYPI20061722 A MY PI20061722A MY PI20061722 A MYPI20061722 A MY PI20061722A MY 149604 A MY149604 A MY 149604A
- Authority
- MY
- Malaysia
- Prior art keywords
- vaccines
- present
- toxoid vaccine
- alpha toxoid
- perfringens alpha
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0258—Escherichia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US67228905P | 2005-04-18 | 2005-04-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
MY149604A true MY149604A (en) | 2013-09-13 |
Family
ID=36820082
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI20061722A MY149604A (en) | 2005-04-18 | 2006-04-14 | C.perfringens alpha toxoid vaccine |
Country Status (25)
Country | Link |
---|---|
US (2) | US8980283B2 (ko) |
EP (1) | EP1874344B1 (ko) |
JP (2) | JP5243951B2 (ko) |
KR (1) | KR20080005277A (ko) |
CN (1) | CN101198352B (ko) |
AR (1) | AR054251A1 (ko) |
AU (1) | AU2006236365B2 (ko) |
BR (1) | BRPI0610843B1 (ko) |
CA (1) | CA2606180C (ko) |
CR (1) | CR9443A (ko) |
DK (1) | DK1874344T3 (ko) |
ES (1) | ES2583484T3 (ko) |
IL (1) | IL186701A0 (ko) |
MA (1) | MA29406B1 (ko) |
MX (1) | MX2007013053A (ko) |
MY (1) | MY149604A (ko) |
NZ (1) | NZ562637A (ko) |
PE (1) | PE20061398A1 (ko) |
RU (1) | RU2434638C2 (ko) |
SG (1) | SG186672A1 (ko) |
TN (1) | TNSN07387A1 (ko) |
TW (1) | TWI311057B (ko) |
UA (1) | UA98099C2 (ko) |
WO (1) | WO2006113772A1 (ko) |
ZA (1) | ZA200709516B (ko) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY149604A (en) * | 2005-04-18 | 2013-09-13 | Schering Plough Ltd | C.perfringens alpha toxoid vaccine |
KR20120042865A (ko) * | 2006-03-30 | 2012-05-03 | 엠브렉스, 인코포레이티드 | 가금류의 예방접종 방법 및 조성물 |
JP5551933B2 (ja) | 2006-04-17 | 2014-07-16 | シェーリング−プラウ・リミテッド | 組み換え弱毒化Clostridium生物体およびワクチン |
US7745175B2 (en) | 2006-10-27 | 2010-06-29 | Dow Agrosciences Llc | Polynucleotides encoding Clostridium perfringens alpha toxin proteins |
KR20090081389A (ko) * | 2006-11-20 | 2009-07-28 | 인터벳 인터내셔널 비.브이. | 백신의 제조를 위한 클로스트리디움 퍼프린젠스 c 형 박테리아의 용도 |
US7820171B2 (en) * | 2007-04-12 | 2010-10-26 | Pradip Maiti | Use of avian anti-methanogen antibodies for reduction of methane production |
WO2009000066A1 (en) | 2007-06-22 | 2008-12-31 | University Of Guelph | Vaccine against clostridium perfringens |
US8956628B2 (en) * | 2007-12-13 | 2015-02-17 | Zoetis Products Llc | Bacteriophage preparations and method of use thereof |
US8293100B2 (en) | 2009-03-13 | 2012-10-23 | Terrasep, Llc | Methods and apparatus for centrifugal liquid chromatography |
US8916162B2 (en) | 2010-02-20 | 2014-12-23 | Alexey Gennadievich Zdanovsky | Botulinum neurotoxin antigenic compositions and methods |
WO2011151941A1 (ja) * | 2010-06-04 | 2011-12-08 | 国立大学法人東京大学 | 制御性t細胞の増殖または集積を誘導する作用を有する組成物 |
CN102008720B (zh) * | 2010-07-20 | 2015-02-25 | 东北农业大学 | 抗魏氏梭菌病转基因植物疫苗及其制作方法 |
US20140377248A1 (en) * | 2011-12-23 | 2014-12-25 | Merz Pharma Gmbh & Co. Kgaa | Method for the manufacturing of di-chain proteins for use in humans |
CN102657683B (zh) * | 2012-06-02 | 2014-05-07 | 哈尔滨工业大学 | 一种免疫类毒素的制备方法 |
CN102698259B (zh) * | 2012-06-12 | 2017-02-08 | 北京中海生物科技有限公司 | 一种鸡坏死性肠炎(a型)灭活疫苗制备方法 |
CN102688484B (zh) * | 2012-06-13 | 2016-03-30 | 北京中海生物科技有限公司 | 一种鸡坏死性肠炎(c型)灭活疫苗的生产方法 |
PL2911688T3 (pl) | 2012-10-26 | 2020-03-31 | Intervet International B.V. | Szczepionki zapewniające ochronę krzyżową przeciwko salmonelli |
CN103463632B (zh) * | 2013-09-05 | 2016-01-06 | 山东农业大学 | 牛羊肠毒血症的d型产气荚膜梭菌类毒素疫苗的制备方法 |
FR3012964A1 (fr) * | 2013-11-12 | 2015-05-15 | Seppic Sa | Vaccins adjuves pour vaccination aviaire in ovo |
CN103861094A (zh) * | 2014-03-27 | 2014-06-18 | 山东农业大学 | 一种产气荚膜梭菌α毒素基因工程疫苗及其应用 |
CN104131022A (zh) * | 2014-08-01 | 2014-11-05 | 中国农业科学院兰州兽医研究所 | 产气荚膜梭菌α、β1、β2、ε毒素共表达载体及其构建方法和表达方法 |
CN104531731B (zh) * | 2014-12-15 | 2018-06-26 | 中国人民解放军军事医学科学院军事兽医研究所 | 产气荚膜梭菌α毒素人源化单链抗体7D |
CN104531730B (zh) * | 2014-12-15 | 2018-07-17 | 中国人民解放军军事医学科学院军事兽医研究所 | 产气荚膜梭菌α毒素人源化单链抗体8B |
CN104531867B (zh) * | 2014-12-25 | 2017-03-29 | 湖北省农业科学院畜牧兽医研究所 | 产气荚膜梭菌肠毒素阳性菌双重荧光定量pcr快速检测试剂盒 |
EP3112474A1 (en) * | 2015-06-29 | 2017-01-04 | Evonik Degussa GmbH | Method of detecting avian necrotic enteritis |
BR112019015140A2 (pt) | 2017-01-23 | 2020-04-14 | Univ Florida | indução de imunidade protetora contra antígenos |
WO2018159476A1 (ja) * | 2017-02-28 | 2018-09-07 | 一般財団法人阪大微生物病研究会 | 多価ワクチン |
JP2020527051A (ja) * | 2017-05-31 | 2020-09-03 | ハー マジェスティー ザ クイーン イン ライト オブ カナダ アズ リプレゼンティッド バイ ザ ミニスター オブ アグリカルチャー アンド アグリ−フードHer Majesty The Queen In Right Of Canada As Represented By The Minister Of Agriculture And Agri−Food | 家禽における壊疽性腸炎に対するワクチン |
JP7349366B2 (ja) * | 2017-06-09 | 2023-09-22 | ヒプラ シエンティフィック エセ.エレ.ウ. | クロストリジウム類毒素を含むワクチン |
MA49771A (fr) | 2017-08-04 | 2020-06-10 | Univ Florida | Induction d'une immunité protectrice contre des antigènes |
CN107596361B (zh) * | 2017-09-12 | 2020-08-14 | 浙江海隆生物科技有限公司 | 牛a型产气荚膜梭菌的亚单位疫苗及其制备方法和应用 |
CN107875377B (zh) * | 2017-11-06 | 2020-01-03 | 山东农业大学 | 一种e型产气荚膜梭菌类毒素疫苗的制备方法 |
CN109954135B (zh) * | 2017-12-25 | 2023-01-31 | 金宇保灵生物药品有限公司 | 牛a型产气荚膜梭菌灭活类毒素疫苗及其制备方法 |
CN108578686B (zh) * | 2018-04-23 | 2022-07-01 | 杨凌凯瑞生物科技有限公司 | 一种制备羊梭菌病基因工程亚单位疫苗的方法 |
CN109111509B (zh) * | 2018-09-19 | 2021-08-13 | 天康制药(苏州)有限公司 | 腐败梭菌α毒素突变体、表达其的基因、制备方法和腐败梭菌疫苗 |
CN111500482B (zh) * | 2019-01-31 | 2023-09-05 | 内蒙古金宇保灵生物技术研究院有限公司 | 一种羊a型产气荚膜梭菌菌株及其灭活疫苗和疫苗制备方法 |
CN109943507B (zh) * | 2019-03-26 | 2021-08-17 | 中国兽医药品监察所 | 一种兽用a型产气荚膜梭菌类毒素的制备方法及其应用 |
CN110041437B (zh) * | 2019-04-29 | 2020-12-25 | 中国兽医药品监察所 | 一种无毒性破伤风毒素和诺维梭菌α毒素重组融合蛋白 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2257230B1 (ko) | 1973-09-14 | 1976-11-19 | Agronomique Inst Nat Rech | |
SU627612A1 (ru) * | 1977-09-30 | 1980-02-05 | Zemlyakova V P | Препарат земл ковой в.п. против клюстридиозов животных и птиц |
CA2136230C (en) | 1992-05-20 | 2008-11-18 | Richard W. Titball | Clostridium perfringens vaccines |
EP0692974B2 (en) * | 1993-03-29 | 2007-05-30 | Pfizer Inc. | Multicomponent clostridial vaccines using saponin adjuvants |
US6048535A (en) | 1997-06-12 | 2000-04-11 | Regents Of The University Of Minnesota | Multivalent in ovo avian vaccine |
ATE526033T1 (de) | 2002-05-21 | 2011-10-15 | Schering Plough Ltd | Verfahren für die kultur von sporozoea sp. in vitro und ihre anwendungen |
ATE505538T1 (de) | 2003-06-09 | 2011-04-15 | Corixa Corp | Dna-vektoren |
WO2005016383A1 (en) | 2003-08-14 | 2005-02-24 | Merial Limited | Compositions and vaccines containing antigen(s) of cryptosporidium parvum and of another pathogen |
CA2897112A1 (en) | 2004-10-05 | 2006-04-20 | Fvg Limited | Compositions comprising an antigen and a promiscuous t-cell epitope |
MY149604A (en) * | 2005-04-18 | 2013-09-13 | Schering Plough Ltd | C.perfringens alpha toxoid vaccine |
KR20090081389A (ko) | 2006-11-20 | 2009-07-28 | 인터벳 인터내셔널 비.브이. | 백신의 제조를 위한 클로스트리디움 퍼프린젠스 c 형 박테리아의 용도 |
-
2006
- 2006-04-14 MY MYPI20061722A patent/MY149604A/en unknown
- 2006-04-17 NZ NZ562637A patent/NZ562637A/en not_active IP Right Cessation
- 2006-04-17 KR KR1020077026795A patent/KR20080005277A/ko active IP Right Grant
- 2006-04-17 BR BRPI0610843-1A patent/BRPI0610843B1/pt active IP Right Grant
- 2006-04-17 PE PE2006000396A patent/PE20061398A1/es not_active Application Discontinuation
- 2006-04-17 UA UAA200712804A patent/UA98099C2/uk unknown
- 2006-04-17 RU RU2007142337/10A patent/RU2434638C2/ru not_active IP Right Cessation
- 2006-04-17 TW TW095113660A patent/TWI311057B/zh not_active IP Right Cessation
- 2006-04-17 CN CN2006800218109A patent/CN101198352B/zh not_active Expired - Fee Related
- 2006-04-17 DK DK06750659.2T patent/DK1874344T3/en active
- 2006-04-17 MX MX2007013053A patent/MX2007013053A/es active IP Right Grant
- 2006-04-17 AR AR20060101501A patent/AR054251A1/es not_active Application Discontinuation
- 2006-04-17 WO PCT/US2006/014669 patent/WO2006113772A1/en active Application Filing
- 2006-04-17 ES ES06750659.2T patent/ES2583484T3/es active Active
- 2006-04-17 EP EP06750659.2A patent/EP1874344B1/en active Active
- 2006-04-17 US US11/405,198 patent/US8980283B2/en active Active
- 2006-04-17 AU AU2006236365A patent/AU2006236365B2/en not_active Ceased
- 2006-04-17 JP JP2008507827A patent/JP5243951B2/ja active Active
- 2006-04-17 SG SG2012093878A patent/SG186672A1/en unknown
- 2006-04-17 CA CA2606180A patent/CA2606180C/en not_active Expired - Fee Related
-
2007
- 2007-10-16 IL IL186701A patent/IL186701A0/en not_active IP Right Cessation
- 2007-10-16 CR CR9443A patent/CR9443A/es unknown
- 2007-10-17 TN TNP2007000387A patent/TNSN07387A1/en unknown
- 2007-10-26 MA MA30321A patent/MA29406B1/fr unknown
- 2007-11-05 ZA ZA200709516A patent/ZA200709516B/xx unknown
-
2011
- 2011-12-26 JP JP2011284090A patent/JP2012062330A/ja not_active Withdrawn
-
2015
- 2015-01-29 US US14/608,577 patent/US9662380B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY149604A (en) | C.perfringens alpha toxoid vaccine | |
TW200806316A (en) | Yeast-based vaccine for inducing an immune response | |
EP1594536A4 (en) | ADJUVANT INFLUENZA VACCINE | |
WO2006068663A3 (en) | Vaccine compositions for treating coronavirus infection | |
WO2007120673A3 (en) | Immunogenic wt-1 peptides and methods of use thereof | |
MA29459B1 (fr) | Vaccins | |
WO2007024947A3 (en) | Canine influenza vaccines | |
MX338898B (es) | Vacuna contra el virus del dengue inactivado con un adyuvante libre de aluminio. | |
CA2763359C (en) | New human rotavirus strains and vaccines | |
WO2009135199A3 (en) | Vaccine compositions and methods | |
GB2386072A (en) | Novel vaccine | |
MX2020008454A (es) | Composicion inmunogenica que comprende antigenos estafilococicos. | |
SG178904A1 (en) | Combination vaccines against respiratory tract diseases | |
TN2019000064A1 (en) | Composition comprising multivalent capsular polysaccharide-transport protein and use thereof | |
MX2021009105A (es) | Toxinas apxia, apxiia y apxiiia inactivadas. | |
CY1112575T1 (el) | Βελτιωμενα αδρανοποιημενα εμβολια fcv | |
CY1116135T1 (el) | Εμβολιο ροταϊου που διεγειρει ετεροτυπικη εγκαρσια προστασια | |
MX2016001695A (es) | Composiciones inmunogenas de combinacion. | |
PH12017501795A1 (en) | Pestivirus vaccines for congenital tremors | |
GB2444676A (en) | Adjuvanted vaccine | |
AU2001284354A1 (en) | Immunological adjuvant compounds, compositions, and methods of use thereof | |
NZ591188A (en) | West nile virus vaccine | |
WO2010080188A3 (en) | Epitope targeted anthrax vaccine | |
MY158116A (en) | Combination vaccine against streptococcus | |
MX2019013779A (es) | Vacuna que comprende toxoides de clostridium. |